Atlas Trials

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19

Clinical trial NCT04764721 · COMPLETED

Trial details

NCT number
NCT04764721
Sponsor
Central Hospital, Nancy, France
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid-19
Start date
2021-11-17
Primary completion
2023-08-15
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.